Clinical Trial: FDA Stays Silent on Trovan Charges

Lagos, Nigeria-FDA refused to confirm or deny that it was launching a criminal investigation into Pfizer’s conduct during a 1996 clinical trial for Trovan (alatrofloxacin) in Nigerian patients.FDA’s "no comment" follows the Washington Post’s report that its Office of Criminal Investigation has been collecting information about the trial of the antibiotic, which has since been approved.

For full article Click Here